Information provided by Blue Cross and Blue Shield of Texas is for informational and educational purposes only and is not a substitute for the independent medical judgment of a physician or other health care provider, nor is the information presented intended to replace or supersede any requirements set forth in your contract with BCBSTX
That growth has already been enjoyed by shareholders of the companies dominating that space, including Novo Nordisk NYSE: NVO, maker of Ozempic and Wegovy, and Eli Lilly NYSE: LLY, maker of Zepound and Mounjaro
Choose a local in-person path for GLP-1 evaluation, follow-up, refill planning, and medication monitoring
I left that consultation knowing I had made the right decision. Post- surgery attention was outstanding, I felt completely comfortable in Dr
This was the first approval of a weight-loss medication specifically for cardiovascular risk reduction, further strengthening the clinical value proposition of GLP-1 therapies In December 2024, the U.S
Long-term treatment with liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has no effect on -amyloid plaque load in two transgenic APP/PS1 mouse models of Alzheimers disease